Tokyo, Japan and Cambridge, UK, 26 January 2026 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2025 on ...

Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...

In a remarkable pivot, Athira Pharma is shifting its primary focus from Alzheimer’s to oncology following a multi-year period marked by clinical failures and leadership turnover. The Bothell, ...

In this article, we will be taking a look at the 9 Most Undervalued Pharma Stocks to Buy Right Now. The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable ...

Despite continued uncertainty and mounting regulatory challenges, pharma TV ad spend topped $7 billion through the first 11 months of 2025. Recently released data by iSpot.tv found that the ...

For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business cycle. There’s enormous pressure to find ways of covering the shortfall.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company was approved for $3 ...

For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door’, where brands prepared to tell their story and hoped ...

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma's plan to settle thousands of lawsuits over the harms of opioids. U.S. Bankruptcy Judge Sean Lane gave ...

This is read by an automated voice. Please report any issues or inconsistencies here. Federal judge approved Purdue Pharma settlement requiring the Sackler family to contribute up to $7 billion and ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for ...